ASX bounces back on Trump’s tariff delay, tech stocks shine, while Seek’s $42m deal crashes and Xref tanks 22pc.

Fresh from FDA approval for its paediatric stem-cell product, Mesoblast is pursuing consent for indications of heart disease ...

Psychedelic drug developer Emyria says the use of MDMA (Molly, or Esstacy) has a lasting effect for post-traumatic stress ...

New York-based analyst Viktor Shvets says the next decade promises to be the most critical in terms of the tech transition.

Trigg Minerals (ASX:TMG) expands and diversifies antimony holdings in NSW with acquisitions including the historic Bukkulla ...

The first major investor conference of the year has kicked off with the Investing in African Mining Indaba event in Cape Town ...

Nasdaq hits record highs, DeepSeek stirs up the AI scene, but Pointerra and Hydrix shine as ASX tech stocks hold strong ...

The maker of sleep devices, Kiwi-based Fisher & Paykel Healthcare expects a Trump tariff hit because it manufactures in ...

China outmanoeuvred the US with the launch of DeepSeek. But the US’s biggest tech companies are fighting back in the AI race.

With prices at all time highs, ASX gold miners could soon be adding more than $1 billion a quarter to their coffers.

Ovanti reported a milestone quarter with former Zip Co US CFO Simon Keast appointed as its new CEO and mandate to launch BNPL ...

Tech small caps enjoyed strong interest in the December quarter as they pivoted to AI and semiconductor technology.